ARL14EP

ARL14EP (ARF7EP/C11orf46) is a bifunctional adaptor protein that operates both in cytoplasmic vesicle transport and in chromatin-based transcriptional repression (PMID:21458045, PMID:31511512). In human dendritic cells it acts as an effector of the GTPase ARL14/ARF7, bridging the activated GTPase to the motor protein myosin 1E to drive actin-based movement of MHC-II vesicles (PMID:21458045). In neurons it is a nuclear protein that associates with the SETDB1 repressor complex to silence axonal guidance genes such as Sema6a, an activity required for transcallosal axonal connectivity; an intellectual-disability-associated R236H mutant fails to rescue this connectivity, and locus-specific recruitment via dCas9-SunTag normalizes SEMA6A expression through repressive chromatin remodeling (PMID:31511512). Its conserved cysteine-rich domain mediates this chromatin role by docking onto the non-canonical methyl-CpG-binding domain of SETDB2, which has lost methylated-DNA binding and instead presents a basic concave surface, an arginine finger, and an intermolecular β-sheet as a protein–protein interaction interface that stabilizes the methyltransferase at chromatin (PMID:38159574, PMID:38458157). This methyltransferase-stabilizing function is conserved to the C. elegans ortholog ARLE-14, which promotes chromatin association of MET-2/SETDB1 together with LIN-65/ATF7IP to regulate the timing of heterochromatin formation and to antagonize SET-25-driven monoallelic silencing during embryogenesis (PMID:30140741, PMID:41315265, PMID:38328214).

1. 2011 Medium

   Established the first molecular function of ARL14EP, defining it as a GTPase effector that physically links ARL14/ARF7 to a myosin motor for cytoskeletal cargo transport.

   Evidence Genome-wide RNAi screen with flow-cytometry MHC-II readouts and complex characterization in primary human dendritic cells

   PMID:21458045

   Open questions at the time

   • No reconstitution or structural validation of the ARL14–ARF7EP–myosin 1E complex
   • Whether this vesicle-transport role operates outside dendritic cells is untested
   • Connection between this cytoplasmic role and the later nuclear/chromatin role is unresolved
2. 2018 Medium

   Identified a distinct chromatin-associated role by showing the C. elegans ortholog binds the H3K9 methyltransferase MET-2/SETDB1 and stabilizes it on chromatin to time heterochromatin formation.

   Evidence Co-immunoprecipitation/binding assays and genetic loss-of-function with heterochromatin readouts in C. elegans embryos

   PMID:30140741

   Open questions at the time

   • Mechanism by which binding promotes chromatin stabilization not defined at this stage
   • Conservation to the human protein not yet demonstrated
   • Single-lab finding using two methods
3. 2019 High

   Demonstrated the human nuclear function and disease relevance: ARL14EP represses axonal guidance genes via the SETDB1 repressor complex to support brain connectivity, with a point mutation abolishing this role.

   Evidence shRNA knockdown with in vivo transcallosal projection readouts, wild-type vs R236H rescue, and dCas9-SunTag epigenetic editing of the Sema6a promoter in neurons

   PMID:31511512

   Open questions at the time

   • Full set of target genes beyond Sema6a not catalogued
   • How nuclear localization is regulated relative to the cytoplasmic effector role is unknown
   • Direct contribution of R236H to interface disruption not structurally resolved here
4. 2023 High

   Provided the structural basis for chromatin recruitment, showing the ARL14EP cysteine-rich domain engages a non-canonical SETDB2 MBD that has repurposed its DNA-binding surface for protein–protein interaction.

   Evidence X-ray crystallography of the SETDB2 MBD–C11orf46 cysteine-rich domain complex with interface analysis

   PMID:38159574 PMID:38458157

   Open questions at the time

   • Structure of the complex with full-length SETDB1 not determined
   • Functional impact of the R236H mutation on the resolved interface not tested in the structure
   • How interface engagement translates into methyltransferase stabilization in vivo not shown
5. 2024 Medium

   Refined the chromatin pathway by placing ARL14EP/ARLE-14 in a MET-2/LIN-65 module that antagonizes SET-25-driven monoallelic silencing, requiring catalytic methyltransferase activity.

   Evidence Genetic epistasis with catalytic SET-domain mutants and monoallelic expression reporters in C. elegans

   PMID:38328214 PMID:41315265

   Open questions at the time

   • Whether the monoallelic-silencing antagonism is conserved in mammals is untested
   • Single-lab finding
   • Direct biochemical link between ARLE-14 binding and SET domain catalysis not established

• How a single protein partitions between a cytoplasmic GTPase-effector/vesicle-transport role and a nuclear methyltransferase-stabilizing role, and whether these functions are coordinated, remains unresolved.
• No study connects the ARL14/myosin 1E vesicle function with the SETDB1 chromatin function
• Regulation of subcellular partitioning is uncharacterized
• Mammalian role in monoallelic expression untested